Hefei TianRui Pharmaceutical Chemical Co., Ltd

Hefei TianRui Pharmaceutical Chemical Co., Ltd.was located in the Industrial Park of Huagang Town, Feixi County, Hefei City, is a pharmaceutical enterprise dedicated to providing domestic and foreign pharmaceutical enterprises with research and development, commercial production and sales of characteristic APIs, CGMP standard intermediates, functional pharmaceutical excipients and MRNA vaccine carriers. The company has excellent research and development capabilities, perfect industrial production facilities and an international CGMP quality management system. The main products that have been independently developed and commercialized include: Roflumilast, rivaroxaban, Ezetimibe, Dasatinib, repaglinide, Prucalopride Succinate, Salcaprozate Sodium, Vandetanib, Garenoxacin, Ropinirole hydrochloride and other new drugs, Among them, Salcaprozate Sodium (8- (2-hydroxybenzamide) octanoate sodium) has successfully obtained the dual registration marks of China's CDE and the US FDA (CDE registration number: F20220000072; DMF number: 037135). Meanwhile, the company also produces intermediate products such as 8-bromooctanoic acid, 8-aminooctanoic acid, 8-bromooctanoic acid methyl ester, 8-bromooctanoic acid ethyl ester, 6-bromooctanoic acid, 7-bromooctanoic acid ethyl ester, dibenzyl phosphate, tetrabenzyl pyrophosphate, and 4- (BOC amino) cyclohexanone. The products are mainly exported to countries and regions such as Europe, the United States, India, Japan, and South Korea, and can meet the quality management, DMF document system, and audit requirements of corresponding regulatory markets. Tianrui Pharmaceuticals is willing to take the lifelong struggle for human health as its mission, and continuously contribute to breaking through the global pharmaceutical industry barriers with reliable products and services.